United Therapeutics Corporation shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in United Therapeutics Corporation by Capital Impact Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $954k | 3.0k | 318.55 |
2023-06-30 | $774k | 3.5k | 220.75 |
2022-12-31 | $278k | 998 | 278.09 |
2022-09-30 | $209k | 998 | 209.42 |
2022-06-30 | $293k | 1.2k | 235.91 |
2022-03-31 | $412k | 2.3k | 179.36 |
2021-12-31 | $1.6M | 7.5k | 216.11 |
2021-09-30 | $2.8M | 15k | 184.60 |
2021-06-30 | $3.2M | 18k | 179.39 |
2021-03-31 | $2.9M | 18k | 167.25 |
2020-12-31 | $2.9M | 19k | 151.80 |
2020-09-30 | $2.2M | 22k | 101.01 |
2020-06-30 | $2.7M | 22k | 121.00 |
2020-03-31 | $5.2M | 55k | 94.83 |
2019-12-31 | $4.6M | 52k | 88.07 |
2019-09-30 | $4.2M | 52k | 80.82 |
2019-06-30 | $2.2M | 29k | 77.02 |
2019-03-31 | $2.3M | 22k | 105.07 |
2018-12-31 | $2.3M | 22k | 105.05 |
2018-09-30 | $3.0M | 24k | 126.37 |
2018-06-30 | $2.6M | 24k | 111.50 |
2018-03-31 | $2.2M | 19k | 112.36 |
2017-12-31 | $2.4M | 16k | 147.95 |
2017-09-30 | $1.9M | 16k | 117.19 |
2017-06-30 | $2.0M | 15k | 129.67 |
2017-03-31 | $2.3M | 17k | 135.44 |
2016-12-31 | $5.2M | 36k | 143.43 |
2016-09-30 | $4.3M | 36k | 118.08 |
2016-06-30 | $3.2M | 30k | 105.92 |
2016-03-31 | $683k | 6.1k | 111.44 |
2015-12-31 | $351k | 2.2k | 156.77 |
2015-09-30 | $294k | 2.2k | 131.31 |
2015-06-30 | $817k | 23k | 34.99 |
2015-03-31 | $386k | 2.2k | 172.40 |
2014-12-31 | $4.7M | 36k | 129.51 |
2014-09-30 | $4.7M | 36k | 128.63 |
2014-06-30 | $1.6M | 18k | 88.50 |
2014-03-31 | $1.7M | 18k | 94.02 |
2013-12-31 | $2.0M | 18k | 113.09 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation